Quasipaa spinosa tadpole anti-inflammatory drug and production method thereof

The invention discloses a quasipaa spinosa tadpole anti-inflammatory drug which comprises the following components in parts by weight: 20-25 parts of coptis chinensis, 10-15 parts of radix paeoniae alba, 10-12 parts of honeysuckle, 5-9 parts of dandelion, 5-9 parts of rehmannia, 20-25 parts of liquorice, 9-12 parts of poria cocos, 9-12 parts of rhizoma anemarrhenae, 10-15 parts of a phagostimulant, 3-5 parts of fructus evodiae, 5-9 parts of nacre mother of pearl, 3-6 parts of uncaria, 5-9 parts of gallnut, 10-13 parts of pinellia ternate, 8-12 parts of fresh ginger and 10-13 parts of Chinese dates. The rhizoma coptidis is matched with the radix paeoniae alba to treat fire excess from yin deficiency, the honeysuckle is matched with the dandelion to enhance the effects of clearing away heat and toxic materials, the medicines are matched to generate a synergistic effect, the rhizoma pinelliae has certain toxicity, and the ginger can eliminate the toxicity of the rhizoma pinelliae, so that the medicinal effect of